Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Scynexis stock
Learn how to easily invest in Scynexis stock.
Scynexis Inc is a drug manufacturers-specialty & generic business based in the US. Scynexis shares (SCYX) are listed on the NASDAQ and all prices are listed in US Dollars. Scynexis employs 56 staff and has a trailing 12-month revenue of around $3.1 million.
How to buy shares in Scynexis
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – SCYX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Scynexis stock price (NASDAQ: SCYX)Use our graph to track the performance of SCYX stocks over time.
Scynexis shares at a glance
|Latest market close||$2.40|
|52-week range||$1.70 - $8.10|
|50-day moving average||$2.55|
|200-day moving average||$3.54|
|Wall St. target price||$18.43|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.20|
Buy Scynexis shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Scynexis stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Scynexis price performance over time
|1 week (2022-09-23)||1.69%|
|1 month (2022-09-01)||-2.44%|
|3 months (2022-07-01)||28.34%|
|6 months (2022-03-29)||-41.32%|
|1 year (2021-10-01)||-53.58%|
|2 years (2020-10-01)||-43.93%|
|3 years (2019-10-01)||126.42%|
|5 years (2017-09-29)||2.41|
|Revenue TTM||$3.1 million|
|Gross profit TTM||$12.9 million|
|Return on assets TTM||-40.51%|
|Return on equity TTM||-125.05%|
|Market capitalisation||$77.1 million|
TTM: trailing 12 months
Scynexis share dividends
We're not expecting Scynexis to pay a dividend over the next 12 months.
Have Scynexis's shares ever split?
Scynexis's shares were split on a 1:10 basis on 17 July 2020. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Scynexis shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Scynexis shares which in turn could have impacted Scynexis's share price.
Scynexis share price volatility
Over the last 12 months, Scynexis's shares have ranged in value from as little as $1.7 up to $8.1. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Scynexis's is 1.9948. This would suggest that Scynexis's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
SCYNEXIS, Inc. , a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of various fungal infections, including recurrent VVC, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections; and ibrexafungerp that has completed Phase 3 CANDLE study for the prevention of recurrent (VVC). It has research collaborations with Merck Sharp & Dohme Corp. , Hansoh (Shanghai) Health Technology Co. , Ltd.
Scynexis in the news
SCYNEXIS to Participate in Upcoming September Investor Conferences
SCYNEXIS to Participate in Upcoming September Investor Conferences
SCYNEXIS Presents Positive Interim Data of Ibrexafungerp for Refractory Candida Infections from Ongoing Phase 3 FURI Study During the Mycoses Study Group Education and Research Consortium (MSGERC) Biennial Meeting
Frequently asked questionsWhat percentage of Scynexis is owned by insiders or institutions?
Currently 1.535% of Scynexis shares are held by insiders and 52.265% by institutions. How many people work for Scynexis?
Latest data suggests 56 work at Scynexis. When does the fiscal year end for Scynexis?
Scynexis's fiscal year ends in December. Where is Scynexis based?
Scynexis's address is: 1 Evertrust Plaza, Jersey City, NJ, United States, 07302-6548 What is Scynexis's ISIN number?
Scynexis's international securities identification number is: US8112922005 What is Scynexis's CUSIP number?
Scynexis's Committee on Uniform Securities Identification Procedures number is: 811292101
More guides on Finder
Alternatives to Webull
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
Best renewable energy stocks for 2022
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
The best dividend stocks for 2022
Our list of 10 dividend stocks to watch in 2022.
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Ask an Expert